A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma
Clinical trial NCT06920901 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06920901
- Sponsor
- Apogee Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-27
- Primary completion
- 2026-09-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.